Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 December, 2014 12:00 IST
Templeton India Growth Fund: Invest
Source: BUSINESS LINE | 21 Jan, 2013, 04.10PM
Comments  |  Post Comment

Investors with a very conservative frame of mind and an investment horizon of at least five years can consider investing in units of Templeton India Growth Fund. The fund follows a strategy of buying and holding stocks for a longer period with a strong thrust on their valuation. Dividends have also been paid out consistently over a ten-year period.

With market valuations soaring over the past year - a result of poor earnings growth and a rapid rise of stock prices - a value-based approach may pay off now. The fund's portfolio PE multiple as December is about 17 times, at a slight discount to the Sensex's 18 times. The fund's PE has also remained steadier in the past three years than the Sensex's wider swings.

The fund may not give out the superlative returns of equity funds, but could protect risk of loss in a falling market. Barring 2011, the fund has managed to contain slide in NAVs during market downturns reasonably.

Performance: Over a one-year period, the fund has returned 26%, beating its benchmark's 20% by a wide margin. Over three- and five-year periods too, the fund has pushed past its benchmark.

On a five-year rolling return basis, though, the fund has bettered its benchmark only about 60% of the time, owing to its underperformance in 2011. Dividends have, however, been paid out during the poor years as well. But the fund's 9.1% SIP return over this period suggests that this may be an optimal route to invest in the fund.

Portfolio: The fund sports a limited portfolio of 25-35 stocks. Large-cap stocks currently dominate the portfolio at around 77%, with a fair share of mid-cap stocks and a limited presence in small-cap stocks. But given that the fund uses valuation parameters in stock picks, this proportion is liable to change.

That the fund prefers stocks out of favour and thus usually undervalued is evident from the lack of pure-consumer stocks and the inclusion of stocks from the fertiliser (11.4%), metals (1.9%), and oil (4.8%) space.

The fund caught the wave of private sector banks rather early, gradually building stake in the sector November 2011 onwards, while booking out of stocks in public sector banks in February 2012.

There are no holdings in stocks of FMCG or retail companies, whose valuations have skyrocketed in the past year. It does have a measure of the consumer angle in picking good performer Maruti Suzuki and telecom stocks such as Bharti Airtel and Idea Cellular. Among tyre stocks, the fund added dark horse Balkrishna Industries, which has turned out to be a good performer. The fund has a defensive play in pharma stock Dr Reddy's Labs.

Taking advantage of their recent good run, the fund recently exited the stocks of Reliance Infrastructure - in which it had been slowly increasing stake from mid-2010 onwards - Usha Martin and Tata Steel. These stocks, along with Union Bank of India, were partly to blame for the poor performance in 2011.

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
CRISIL assigns fundamental grade 4/5 to JSW Steel - 19-Dec-2014 16:18
Emkay maintains `Buy` on L&T - 19-Dec-2014 15:43
Panacea Biotec join hands with Rising Pharmaceuticals - 19-Dec-2014 11:59
Petron Engineering gets LoI for contract worth Rs 240 mn - 19-Dec-2014 11:49
Dr Reddy's closes acquisition of Habitrol brand from Novartis - 19-Dec-2014 11:29
JET Airways introduces 12 additional domestic frequencies - 19-Dec-2014 10:56
Balaji Telefilms joins Indus Media to enter American television market - 19-Dec-2014 10:38
Punj Lloyd gets FIPB nod for manufacture of defence items - 18-Dec-2014 19:17
FIIs can invest up to 100% in Crompton Greaves: RBI - 18-Dec-2014 18:57
FIIs can invest up to 49% in Tree House Education: RBI - 18-Dec-2014 18:40
Logistics companies to be biggest beneficiaries of GST: Allcargo Logistics - 18-Dec-2014 16:40
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer